Latest Breaking News On - Relmada therapeutics - Page 1 : vimarsana.com

AdvisorShares Investments LLC Has $309,000 Position in Relmada Therapeutics, Inc. (NASDAQ:RLMD)

AdvisorShares Investments LLC cut its stake in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 33.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 74,666 shares of the company’s stock after selling 38,242 shares during the period. AdvisorShares Investments LLC owned 0.25% of […]

United-states
Relmada-therapeutics-inc
Mirae-asset-global-investments-co
Advisorshares-investments
Guild-investment-management-inc
Silverarc-capital-management
Goldman-sachs-group
Nasdaq
Relmada-therapeutics
Free-report
Shares-investments

Q2 2024 Earnings Estimate for Relmada Therapeutics, Inc. (NASDAQ:RLMD) Issued By Leerink Partnrs

Q2 2024 Earnings Estimate for Relmada Therapeutics, Inc. (NASDAQ:RLMD) Issued By Leerink Partnrs
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Leerink-partnrs
Silverarc-capital-management
Opaleye-management-inc
Relmada-therapeutics-inc
Parsons-capital-management-inc
Guild-investment-management-inc
Nasdaq
Relmada-therapeutics
Free-report
Relmada-therapeutic
Get-free-report

RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024

RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Relmada-therapeutics
Place-earnings

Relmada Therapeutics (RLMD) Set to Announce Earnings on Wednesday

Relmada Therapeutics (RLMD) Set to Announce Earnings on Wednesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Relmada-therapeutics-inc
Relmada-therapeutics
Get-free-report
Relmada-therapeutics-daily

Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024

CORAL GABLES, Fla., May 6, 2024 /PRNewswire/ Relmada Therapeutics, Inc. , a late-stage biotechnology company addressing diseases of the central nervous system , today announced that it will.

Tim-mccarthy
Prnewswire-relmada-therapeutics-inc
Corporate-communications
Nasdaq
Relmada-therapeutics-inc
Securities-exchange
Conference-call
Relmada-therapeutics
Private-securities-litigation-reform-act
Securities-act
Securities-exchange-act
Markets